| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities: | ||||||||
Net loss | ||||||||
-44,634 | -43,037 | -34,685 | -27,253 | -20,993 | -16,237 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Stock-based compensation expense | ||||||||
7,276 | 5,565 | 3,711 | 2,045 | 1,044 | 867 | 0 | 0 | 0 |
Depreciation expense | ||||||||
1,512 | 1,400 | 2,309 | 1,714 | 757 | 600 | 0 | 0 | 0 |
Non-cash operating lease expense | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Other non-cash items | ||||||||
-42 | -52 | -59 | -53 | -68 | -7 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
8,420 | 3,619 | 2,879 | 2,950 | 1,481 | 4,991 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||||
2,655 | 6,005 | 7,904 | 10,272 | 9,871 | 7,049 | 0 | 0 | 0 |
Other non-current assets | ||||||||
-1,106 | -869 | 868 | 7,620 | 1,656 | 1,465 | 0 | 0 | 0 |
Accounts payable | ||||||||
7,805 | 4,203 | 5,505 | 3,993 | 3,077 | 3,413 | 0 | 0 | 0 |
Deferred revenues | ||||||||
-487 | -4,442 | -3,416 | -3,621 | 7,652 | 8,587 | 0 | 0 | 0 |
Operating lease liabilities | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Accrued expenses and other liabilities | ||||||||
1,357 | 4,012 | -1,186 | 3,293 | 1,497 | 1,230 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-36,803 | -41,731 | -39,314 | -36,996 | -22,082 | -14,998 | 0 | 0 | 0 |
Investing activities: | ||||||||
Purchases of property and equipment | ||||||||
1,798 | 1,999 | 1,203 | 1,121 | 2,288 | 2,150 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||
-1,798 | -1,999 | -1,203 | -1,121 | -2,288 | -2,150 | 0 | 0 | 0 |
Financing activities: | ||||||||
Payments related to finance leases | ||||||||
78 | 1,437 | 0 | 0 | 0 | - | - | - | - |
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | ||||||||
- | 37,274 | 37,274 | 37,274 | 37,274 | 6,439 | 0 | 0 | 0 |
Proceeds from issuance of common stock, net of issuance costs | ||||||||
0 | - | - | - | - | - | - | - | - |
Payments for deferred offering costs | ||||||||
- | - | - | - | 0 | - | - | - | - |
Proceeds from borrowings | ||||||||
- | - | - | - | - | 425 | 0 | 0 | 0 |
Repayments of borrowings | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Net cash provided by financing activities | ||||||||
73,310 | 109,751 | 110,640 | 111,167 | 35,151 | 6,873 | 0 | 0 | 0 |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||||
34,709 | 66,021 | 0 | 0 | 0 | - | - | - | - |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||||
-340 | -1,026 | 0 | 0 | 0 | - | - | - | - |
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for interest | ||||||||
0 | - | - | - | - | - | - | - | - |
Net decrease / increase in cash and cash equivalents | ||||||||
- | - | - | - | - | - | - | - | 0 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||
- | - | - | - | - | - | - | - | 0 |
Cash paid for income taxes | ||||||||
0 | - | 107 | 99 | 25 | 24 | 0 | 0 | 0 |
Supplemental disclosure of non-cash investing activities: | ||||||||
Property and equipment additions in accounts payable and accrued expenses | ||||||||
0 | - | - | - | 0 | - | - | - | - |